12 ΦΘΙΝΟΠΩΡΟ 2010 Η επιτυχία ΕΝΘΕΤΟ! MY LIFE Θεσσαλίας του ΜΗΤΡΙΚΟΥ ΘΗΛΑΣΜΟΥ Μήνας Πρόληψης του ΚΑΡΚΙΝΟΥ ΤΟΥ ΜΑΣΤΟΥ ΟΚΤΩΒΡΙΟΣ Εγκυμοσύνη & Γυμναστική Εγχρωμο DOPPLER Κυήσεως ΠΑΙ Ι & Ανάπτυξη Αλήθειες για το ΚΑΠΝΙΣΜΑ ΑΞΟΝΙΚΗ ΕΝΤΕΡΟΓΡΑΦΙΑ ΕΓΚΕΦΑΛΙΚΟ ΕΠΕΙΣΟ ΙΟ Ηπατίτιδα Β' & ΚΥΗΣΗ
Editorial ial,! -,., - - My Life -,. General - -., My Club Card VISA - check up., MYLIFE 1
index 04 08 10 General 12 & 18 Doppler 22 26 30 ' 34 38 42 44 MY CLUB CARD VISA 48 + " LIFE " 2 MYLIFE
MYLIFE 3
-. -, -,., -,. : ; ; ; ; - -. -.. -.. - -. -.,,,. -, - -. 4 MYLIFE
..., -..., -.. -, -.. -., -,.,. -, -....,,.,.., -. MYLIFE 5
... -., -. -.,, -.,, -,. -,. -.,,.,.,.., -.. -.! -., -,,. - -... 6 MYLIFE
MYLIFE 7
., 12,5% 3,4%.,, 35-55. 1940. -. : Ca. : :.. BRCA1, - -, 2, 5% Ca. : 1. ( - ),,,. 2. > 30. 3. (... Hodykin s). 4. - -. 5. (,,, ). 8 MYLIFE
,,. Ca,,., -. 18 -. 35, -. 40. (...), -, : Ca -,,,, -,,.,. -. -,..,.. 1. National Center for Health statistics SEER Cancer Statistics Review 1973-1995. Bethesda, MD: National Cancer Institute 1998. 2. Ries L, Elsner M, Kosary C. et.al. SEER cancer statistics review, 1975-2000. Bethesda, MD: National cancer institute 2003. 3. Surveillance, Epidemiology and End Results (SEER) Program. Limited-use data (1973-2005), National Cancer Institute, DCCPS, Surveillance Research Program, cancer statistics Branch, released April 2008. 4. Diseases of the Breast Fourted J.R. Harris, Lippman ME, Morrow M, Osborn E ck. 2010 Lippincott Williams and Wilkins ed, Chapter 18. 5. Olopade OI, Genetics in clinical cancer care: a promise unfulfilled among minority populations. Cancer Epidemiology Biomakers prev 2004: 13: 1683-1686. 6. Diseases of the Breast Fourted J.R. Harris, Lippman ME, Morrow M, Osborn E ck. 2010 Lippincott Williams and Wilkins ed, Chapter 20: Nongenetic factors in the Causation of breast cancer. 7. Smith RA, Cokkinides V, Eyre HJ, American cancer society for the early detection of cancer 2003, C.A. Cancer J Clin 2003; 53(1): 27-43. 8. National Cancer Institute. NCI statement in mammography screening. Bethesda MD: NCI, 2002. MYLIFE 9
General General,, -,, -. (triple assessment), -,. General - -., - -,, -. - SUROS HOLOGIC... -.,, - -, ROLL technique- Radioisotope Occult Lesion Localization (, ). General E, - -,. -,,, -. Royal College Of Surgeons Of England, -., -,.,,, -. ( ) - & ( ) SUROS HOLOGIC. General MD, PHD - / MD, MD - MD - MD MD - MD - MD - MD - MD - 10 MYLIFE
General, General «H» - 75%. 13 19.30, 55. K General,. MD Ph.D. O. - MD MD,. MD,, -,. o General,, 17.00 19.00,, ( ) 120 31 2010. -,. 98 100,,... 40 -.,,, -.,. -,,. :,.: 210-6185227 General,.: 210-6502510-1 www.iaso.gr MYLIFE 11
&.,,. -,., : &,..,., ( ),,. - Journal of Pediatrics,.,.. MD., I 12 MYLIFE
& H,,. -..,. 90,,...,,. - ( ). -.,,,, -. -., -,, -, -,,, -. MYLIFE 13
1 2 3 30,.. 25.. 30., 2, -. 20. -,.. 1,., -. 30..,,,.., -. -,,,. - -,. &, 1..,.,,..!,,. 14 MYLIFE
& M,,. 0 3 4 9, - -. -,,. -,. 0 5., -.,,., -. -,,.. - -. 10 18. -, - -. - /. - -. -. - -. MYLIFE 15
, : & : - -. -., -,,. : -.,., -, -. : -,. - (,,, ) - -., -,. : - (..,, -, ) (..,, )., -.,. : -.. :., -. 16 MYLIFE
. - -.,, -.,, - -,., ',,. : Ujjayi,, - Nadi Shodhana ( ),,. pranayama -.,,,,. -., -, -., '.., -.,.,,., -. 1. www.yogaonline.gr 2. health.in.gr/gym/narticl 3. www.sigmalive.com MYLIFE 17
Doppler Doppler ; Doppler. - -,., -,. ; : -. : S/D ( - ) RI ( ) PI ( ) :,, Doppler, -, -. -. -. - B' 18 MYLIFE
Doppler. ; Doppler (PI,RI,S/D) -., -. Doppler ; - (21-24 ). 10-15%. - -. - -. - - -.,. Doppler 3 ;.. -. MYLIFE 19
3 ; - Doppler ;. - -.. ; Doppler,, -. : : - / - -. : -. : - Doppler,, - ( ) -., - ( -Brain sparing effect). -,,, -. : 50%. - ( - ). - ( - ) -. -. 20 MYLIFE
Doppler Doppler 3. Doppler ; -. ( Rhesus 19)., - :,. Doppler,,, - ( ). -, -. Doppler ( ). Doppler ;.,, (Doppler).. -.. 1. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening - K. H. Nicolaides 1 *, K. Spencer 2, K. Avgidou 1, S. Faiola 1, O. Falcon 1 2. The Fetal Medicine Foundation. Tricuspid regurgitation: newest ultrasound marker to be included in first trimester risk calculation. Fetal Med Found 11–13+6 Weeks Scan Project U S Newslett. 2006;2:2. 3. Bahado-Singh R, Ray O, Wapner R, et al. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol. 2005;192:1357 1361 4. P, Breheny N, Dickinson JE, et al. First-trimester combined screening for Down syndrome and other fetal anomalies. Obstet Gynecol. 2006;107:869 876. 5. Cicero S, Johnson JM, Nicolaides K. Sonographic Markers of Fetal Chromosomal Defects. In: Rumack CM, Wilson SR, Charboneau JW, eds. Diagnostic Ultrasound. 3rd ed. St Louis, MO: Elsevier Mosby; 2005:1157 1183. 6. American College of Obstetrics and Gynecology. Screening for Fetal Chromosomal Abnormalities. Washington, DC: American College of Obstetrics and Gynecology; 2007. ACOG Practice Bulletin No. 77. 7. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10 14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-a. Ultrasound Obstet Gynecol. 1999;13:231 237. 8. Sonek JD, Cicero S, Neiger R, Nicolaides KH. Nasal bone assessment in prenatal screening for trisomy 21. Am J Obstet Gynecol. 2006;195:1219 1230 9. Papageorghiou AT, Yu CK, Erasmus IE, Cuckle HS, Nicolaides KH. Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG 2005;112:703-9. MYLIFE 21
& : ( ) : (,,, ),, -, -, -,,, / - 22 MYLIFE
&,.,. (5 ),..,,,,,.,,. - «,»,, 2-3.., «, ;» «;» «;»,., «,»,,. «;», «,»., : «!»,, 2-3..,,., MYLIFE 23
!,,,,,,,,,,, & &,,, :,, :, (,, ) 1. The Society of Developmental and Behavioral Pediatrics http://www.sdbp.org/ 2. American speech and language hearing association www. asha.org/default.htm 3. L. Polnay Community Paediatrics 3rd edition Churchil Livinstone 2002 24 MYLIFE
MYLIFE 25
- -. : - ( : WHO), ( : World Bank). 4000-250 - (,,,, ) 50 - (,. / General,,,, -,, -210, ). T ( ). 80.000. 438.000. 40%, 35% - 25%. & General 26 MYLIFE
4000 250. : 1. :, 350.000. 90%.. : -,, -,.. - 300.000. 2. -. <65. 3. -,,,,,,, -. 4.,,,,,,,, -. MYLIFE 27
. 50%. :,. - :,,, -,,,,, -. -. -.,,. - 30 90%. 50 50%. - 60...,. 28 MYLIFE
! -,,. - -, - -. General., -, ( ),. - ( )..,, -. 1 7 6, -. 2 4 4,.,,. 210 650 2653 General 210 650 2000 My Club Card VISA General 6 7 & 3 4.,, i! MYLIFE 29
',. -, 1/3 - HBV. 380. HBV, 15-25%, (...).,, -., - HBV. - (HBV),, -. ' ' (HBV) HBV Hepadna DNA. - - HbsAg. - DNA (HBV-DNA), DNA, - 42 nm & Dane DNA πολυμεράση L Ηπατίτιδα Β επιφανειακό αντιγόνο Μ Αντιγόνο Core S Προτεϊνική κινάση DNA (διπλής έλικας), 3200 bp HBsAg = Επιφανειακό αντιγόνο (4 φαινοτύποι: adw, adr, ayw & ayr) HBcAg = Εσωτερικό Core αντιγόνο (1 ορότυπος) HBeAg = Eκκρινόμενη πρωτεϊνη, άγνωστη λειτουργία C, HbcAg, e HbeAf. HBV, - HbcAg HbeAg, -, HBV. HbcAg - HBV, e HbeAg,. HbeAg HBV-DNA, HBV.., -, / General 30 MYLIFE
' B,,. HBV - -.,,, ( HBV >8%), ( HBV 2-7%) (<2%) - ( 2,1%). ΦΑΣΕΙΣ HBV ΛΟΙΜΩΞΗΣ, - HBV.,,,,..,, -, (HBsAg Anti-HBs) 70-90%,,. Φυσική Ιστορία της HBV Ανάπτυξη HBeAg(-) Χρόνια Ηπατίτιδα Β Φάση Ανοσοαντοχής WILD-TYPE ΗΒV HBeAg ΘΕΤΙΚΟ Κάθαρση HBeAg HBeAg ΑΡΝΗΤΙΚΟ anti HBe ΘΕΤΙΚΟ Φάση Χαμηλού Πολλαπ/σμού Ενεργοποίηση HBV ΗΒV ΣΤΕΛΕΧΗ ΜΕΤΑΛΛΑΓΜΕΝΑ,,, - 10-60%., HBV -. &.,,. HBV -.,,. -, HBV-DNA.,,,,. B,. B,, -., - ( HBV >8%), -. -, -, 42% B, 15%, 21%. MYLIFE 31
HBV B,,. -,, B. -,,. - HBV, - HbeAg, HBV-DNA 105 copies/ml). -,. HBV -, B. HBV -.,, - > 90%, -, < 5%. HBV ', - HBV : HBV B, HBV (= HbeAg HBV-DNA )., -, -, - -,,. - ', - 10%, ' 60%..,, -, -. 32 MYLIFE
' HBV,. - HBV,,. >8%. HBV., B HbeAg +, 70-90%., 10-40%,. HBV-DNA, -. HBV- DNA 105 copies/ml,, - HBV-DNA >108 Copies/ml. - / > 90%,, - /., - HBV, - (HbeAg + HBV-DNA>105 copies/ ml). -, ' -, ( ) -. - ' - HBV. Lamivudine (LMV) (Zeffix) B, ' -. Lamivudine (LMV) C F.D.A.,, Tenofovir (TFV) (Viread) F.D.A. - LMV 2,5% - ', 1,6% TFV (10),. 1. Alter MJ. Epidemiology of Hepatitis B in Europe and worldwide. J.Hepatol 2003;39 (suppl.1):64-9 2. Kane M.Global program for control of hepatitis B virus infection. Vaccin 1995;13 (suppl 1):47-9 3. Alter JH. Epidemiology and prevention of Hepatitis B. Semin Liver Dis 2003;23:39-46 4. Lok AS, Heathcote E, Hoofnagle J. Management of Hepatitis B:2000-Summary of a workshop. Gastroenterology 2001;120(7):1828-1853 5. Xu DZ, Van YP, Liu ZH, Wang FS. Risk factors and mechanism of transplacent transmission of Hepatitis B virus. J.Med Virol 2002;67:20-26 6. Lao TT, Ben CP, Lai-Fong Ho, Ka-Yu Tse. Maternal Hepatitis B infection and gestational diabetes mellitus. J. of Hepatol. July 2007;47(1):46-50 7. Sinha.S, Kumar.M. Pregnancy and chronic Hepatitis B virus infection. Hepatology Res Jan 2010,40(1):31-48 8. Wiseman.E, Fraser.M, Heron.L, Ayres.A, Levy.T. Perinatal transmission of Hepatitis B virus: An Australian experience. M.JA 2009,190(1):489-492 9. Xu W.M. et.al. Lamivudine in late pregnancy to prevent perinatal transmission of Hepatitis B virus infection. J.Viral.Hepat, 2009,16:94-103 10. Brown B et.al. AASLD 2009 poster 407 11. : -.347-349, 2008,.., MYLIFE 33
. 35.000..,,, - -, -. -. H - - -, General. 25%. General -, -,, -,. 24 24 -. General 34 MYLIFE
,.. - - -, -. -. 85% -. -... 2 -. 30-90%. -, 20% 55. MYLIFE 35
General -. -. - time is brain -. -. - -. -. - 25% -. ( 25-40%) - 5-10%. - - - (tpa) 4.5. - -. 20% 40%.. -, - -.. -. - - - 70-80%. -.. - -,,. -. General - /. 36 MYLIFE
MYLIFE 37
; (CT). -, - ( ), - -. -. -. / General - -.,. - -. General 38 MYLIFE
. ; - 6.. - 1000 1200ml, 30 40. -,. -. 20. - -.. -. -, ( Crohn ), ( - ), ( - ),, -. MYLIFE 39
,, - - (, )., - (. )., - -, 2 3..,, -. General. -, (ESGAR Annual Meeting 2010) General,, : 210 6502510-11 1. Graca BM, Freire PA, Brito JB, Ilharco JM, Carvalheiro VM, Caseiro Alves F Gastroenterologic and Radiologic Approach to Obscure Gastrointestinal Bleeding: How, Why, and When? Radiographics 2010; 30: 235-252 2. CT Enterography: Noninvasive Evaluation of Crohn s Disease and Obscure Gastrointestinal Bleed Radiol Clin North Am 2007; 45: 303-316 40 MYLIFE
Club 800-11-542376 L I B E R O www.liberoclub.gr
& (0% BPA) H Chicco Natural Feeling 0% BPA -, -. Natural Feeling 0% BPA -,.., -. 0% BPA Chicco. -,,. Chicco:. Frezyderm Frezyderm 48,06 shopping bag,,., FREZYDERM, -. 2003 FREZYDERM ISO 9001:20. FREZYDERM : Hair Line, Skin Line, Feminine Essentials, Spot End, Ac-Norm, Baby Line, Sun Screen,,. Harmony & Calma & MEDELA: 50! Medela - - 2- -. Calma,. Calma,,,, - -. www.klinicum.gr 42 MYLIFE
KIDSCOM KIDSCOM Recaro Acuna travel system., young profi plus. - (10.5kg)... 6.. 128,, : 210 8067150. 62,, : 210 9830570 www.kidscom.gr - kidscom 2010.. - Kidscom -,. kidscom - Atlanta Cordoba - kidscom.! -., - -,. -, -,. : & 4 4 6.
General, 20,. 20., 60% :, <65, > 65., ( ).,. ' " ". -.. General, : H 210 650 2569 7.00. 19.00., 18-24,, -.. », : 12, 10%,. GENERALI. 44 MYLIFE
, My Club Card VISA VISA. chip.,., "My Club Card VISA ",. : : : 210 6184444 210 6184111 Fax: 210 6184094 GENERAL: : 210 6502660 E-mail: myclubcard@iaso.gr My Club Card My Club Card VISA., My Club Card VISA.,,. MYLIFE 45
My Club Card VISA! My Club Card VISA :. (, Lux,, Superior : 12 - Superior : 6 ). 6. 6,. 5 Laser -. 12 (Cryobanks). 15% ( - ). 6 (IVF). My Club Card VISA : 20. 20% (, & ). 20% ( /. : ( S500 - S2,500 4 S2,500 6 ). 1, 1 & 1. 150 (,.. & Triplex ). ( ). : -, Triplex & ( ). 46 MYLIFE 46 MYLIFE
My Club Card My Club Card VISA! My Club Card VISA General : : ( S1,000 - S3,000 4 S3,000 6 ). 15%. S15 :,, & 6 FNA 6 7 & 3 4 ( ). My Club Card VISA : : ( S501 - S1,000 2, S1,001 - S2,000 3, S2,001 - S5,000 4 S5,001-6. (Cryobanks) 12 3 " " check-up My Club Card VISA, My Club Card VISA. S4,000,.. 210-618 4070 check up. MYLIFE 47 MYLIFE 47
O [ 210 6383052 ] - [ 210 6383242 ] - [ 210 6383254 ] - [ 210 6383255 ] - [ 210 6383243 ] - [ 210 6383241 ] - [ 210 6184389 ] - [ 210 6383241 ] - [ 210 6383252 ] [ 210 6383241 ] [ 210 6383107 ] - [ 210 6184258-9 ] [ 210 6383101-3 ] [ 210 6502944-2973 ] [ 210 6502641 ] [ 210 6502123 ] & [ 210 6502653 ] - / [ 210 6502000 ] [ 210 6502964 ] - [ 210 6502000 ] - [ 210 6502000 ] - [ 210 6502624 ] [ 210 6502947 ] [ 210 6502000 ] [ 210 6502569 ] [ 210 6502000 ] [ 210 6502000 ] [ 210 6502000 ] [ 210 6502000 ] [ 210 6502200 ] [ 210 6502000 ] [ 210 6502000 ] [ 210 6502000 ].. [ 210 6502925 ] [ 210 6502920-21 ] [ 210 6502623 ] [ 210 6502000 ] (...) [ 210 6502000 ] ( ) [ 210 6502589-90 ] [ 210 6502691-2591 ] / :. 37-39, 151 23,,. 210 6383000, Fax. 210 6383073 www.iasopaidon.gr [ 210 6383000 ] - [ 210 6383249 ] - [ 210 6383245 ] -.. [ 210 6383246 ] - [ 210 6383248 ] - [ 210 6383070 ] - [ 210 6383255 ] - [ 210 6383070-2 ] - [ 210 6383064-5 ] [ 210 6383076 ] [ 2106383248 ]. / & [ 210 6383241 ] - [ 210 6383241 ] General. 264, 155 62,. : 210 6502000, Fax: 210 6541267 www.iasogeneral.gr (O.D.C.) [ 210 6502117 ] [ 210 6502519 ] [ 210 6502000 ] [ 210 6502963-64 ] [ 210 6502629-23 ] [ 210 6502623-24 ] - H [ 210 6502519 ] - [ 210 6502561 ] K M [ 210 6502994-2139 ] [ 210 6502000 ] - [ 210 6502000 ] Laser (LVR) [ 210 6502000 ] [ 210 6502000 ] [ 210 6502642 ] [ 210 6502904-5 ] [ 210 6502608 ] [ 210 6502000 ] [ 210 6502926 ] - [ 210 6502558 ] [ 210 6502544 ] [ 210 6502545 ] [ 210 6502510-11 ] [ 210 6502569 ] 12 ΦΘΙΝΟΠΩΡΟ 2010 Η επιτυχία ΕΝΘΕΤΟ! MY LIFE Θεσσαλίας του ΜΗΤΡΙΚΟΥ ΘΗΛΑΣΜΟΥ Εγκυμοσύνη & Γυμναστική Εγχρωμο DOPPLER Κυήσεως ΠΑΙ Ι & Ανάπτυξη Μήνας Πρόληψης του ΚΑΡΚΙΝΟΥ ΤΟΥ ΜΑΣΤΟΥ ΟΚΤΩΒΡΙΟΣ MY LIFE MAGAZINE 12 2010 Αλήθειες για το ΚΑΠΝΙΣΜΑ ΕΓΚΕΦΑΛΙΚΟ ΕΠΕΙΣΟ ΙΟ ΑΞΟΝΙΚΗ ΕΝΤΕΡΟΓΡΑΦΙΑ Ηπατίτιδα Β' & ΚΥΗΣΗ MedStem Services. 37-39, : 210 6184000 Fax: 210 6184158 www.iaso.gr & - 10 DESIGN - 48 MYLIFE